£3.2M
The extension financing was led by Parkwalk to support clinical trials for the company's knee repair technology.
Orthox develops natural implants to repair damaged knee cartilage.
Orthox is an Oxford spinout developing natural biomaterial implants to repair damaged knee cartilage and orthopaedic injuries.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Orthox's latest Companies House filing — with year-on-year movement, free with a Winfred account.
The extension financing was led by Parkwalk to support clinical trials for the company's knee repair technology.